UA66807C2 - Композиція для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та запобігання зловживанням алкоголем у здорових осіб і спосіб її виготовлення (варіанти) - Google Patents

Композиція для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та запобігання зловживанням алкоголем у здорових осіб і спосіб її виготовлення (варіанти)

Info

Publication number
UA66807C2
UA66807C2 UA2000041867A UA00041867A UA66807C2 UA 66807 C2 UA66807 C2 UA 66807C2 UA 2000041867 A UA2000041867 A UA 2000041867A UA 00041867 A UA00041867 A UA 00041867A UA 66807 C2 UA66807 C2 UA 66807C2
Authority
UA
Ukraine
Prior art keywords
alcohol
alcoholics
craving
abuse
preventing
Prior art date
Application number
UA2000041867A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Альдо Фассі
Клаудіо Кавазза
Original Assignee
Сігма-Тау Індустріе Фармачеутіке Ріуніте С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сігма-Тау Індустріе Фармачеутіке Ріуніте С.П.А. filed Critical Сігма-Тау Індустріе Фармачеутіке Ріуніте С.П.А.
Publication of UA66807C2 publication Critical patent/UA66807C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Addiction (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
UA2000041867A 1997-10-03 1998-09-18 Композиція для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та запобігання зловживанням алкоголем у здорових осіб і спосіб її виготовлення (варіанти) UA66807C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000594A IT1295408B1 (it) 1997-10-03 1997-10-03 Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
PCT/IT1998/000249 WO1999017623A1 (en) 1997-10-03 1998-09-18 Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects

Publications (1)

Publication Number Publication Date
UA66807C2 true UA66807C2 (uk) 2004-06-15

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000041867A UA66807C2 (uk) 1997-10-03 1998-09-18 Композиція для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та запобігання зловживанням алкоголем у здорових осіб і спосіб її виготовлення (варіанти)

Country Status (27)

Country Link
US (1) US6255346B1 (enExample)
EP (1) EP1022960B1 (enExample)
JP (1) JP2001518484A (enExample)
KR (2) KR100530368B1 (enExample)
CN (1) CN1092939C (enExample)
AT (1) ATE220860T1 (enExample)
AU (1) AU730740B2 (enExample)
BG (1) BG64363B1 (enExample)
BR (1) BR9812604A (enExample)
CA (1) CA2305598C (enExample)
CZ (1) CZ291801B6 (enExample)
DE (1) DE69806788T2 (enExample)
DK (1) DK1022960T3 (enExample)
EA (1) EA002177B1 (enExample)
EE (1) EE04036B1 (enExample)
ES (1) ES2180200T3 (enExample)
HU (1) HUP0004336A3 (enExample)
IS (1) IS2234B (enExample)
IT (1) IT1295408B1 (enExample)
MX (1) MXPA00003232A (enExample)
NO (1) NO20001688L (enExample)
NZ (1) NZ503663A (enExample)
PL (1) PL189663B1 (enExample)
PT (1) PT1022960E (enExample)
SK (1) SK283384B6 (enExample)
UA (1) UA66807C2 (enExample)
WO (1) WO1999017623A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
RU2300376C2 (ru) * 2005-05-11 2007-06-10 МУЗ Городская клиническая больница №3 им. М.А. Подгорбунского г.Кемерово Способ лечения при алкогольном делирии
CN101766672B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766715B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766717B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766716B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766635B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766637B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN106176756A (zh) * 2015-04-30 2016-12-07 刘力 包含手性异构化合物的赖氨酸五维药物组合物及其用途
US20230149338A1 (en) * 2020-04-14 2023-05-18 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
EP0776604B1 (en) * 1995-12-01 2002-01-23 Unilever N.V. Microwavable crispy bread-rolls
DK0793962T3 (da) * 1996-03-04 2000-05-22 Sigma Tau Ind Farmaceuti Lægemiddel indeholdende et carnitinderivat til behandling af arteriosclerosis obliterans

Also Published As

Publication number Publication date
EE200000235A (et) 2001-06-15
EP1022960A1 (en) 2000-08-02
WO1999017623A1 (en) 1999-04-15
IS5416A (is) 2000-03-24
EA002177B1 (ru) 2002-02-28
EP1022960B1 (en) 2002-07-24
CZ20001207A3 (cs) 2000-11-15
KR100560097B1 (ko) 2006-03-13
NO20001688L (no) 2000-06-02
EA200000377A1 (ru) 2000-10-30
HUP0004336A2 (hu) 2001-05-28
NO20001688D0 (no) 2000-03-31
NZ503663A (en) 2001-11-30
CA2305598A1 (en) 1999-04-15
HUP0004336A3 (en) 2001-07-30
US6255346B1 (en) 2001-07-03
PL339621A1 (en) 2001-01-02
CA2305598C (en) 2007-11-20
EE04036B1 (et) 2003-06-16
BR9812604A (pt) 2000-08-01
ATE220860T1 (de) 2002-08-15
DE69806788D1 (de) 2002-08-29
MXPA00003232A (es) 2004-03-10
DK1022960T3 (da) 2002-11-04
DE69806788T2 (de) 2003-04-03
PT1022960E (pt) 2002-12-31
CZ291801B6 (cs) 2003-05-14
BG64363B1 (bg) 2004-12-30
KR100530368B1 (ko) 2005-11-22
IT1295408B1 (it) 1999-05-12
CN1092939C (zh) 2002-10-23
JP2001518484A (ja) 2001-10-16
SK4762000A3 (en) 2000-10-09
KR20010030928A (ko) 2001-04-16
AU730740B2 (en) 2001-03-15
AU9366098A (en) 1999-04-27
HK1028714A1 (en) 2001-03-02
CN1276704A (zh) 2000-12-13
PL189663B1 (pl) 2005-09-30
KR20050088499A (ko) 2005-09-06
BG104286A (en) 2000-11-30
ES2180200T3 (es) 2003-02-01
IS2234B (is) 2007-04-15
SK283384B6 (sk) 2003-06-03
ITRM970594A1 (it) 1999-04-03

Similar Documents

Publication Publication Date Title
UA66807C2 (uk) Композиція для подолання абстинентних симптомів та потягу до алкоголю в алкоголіків та запобігання зловживанням алкоголем у здорових осіб і спосіб її виготовлення (варіанти)
Park et al. Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double‐blind, placebo controlled intervention trial
EP0903143A3 (en) Use of daidzein for the manufacture of a medicament for incraesing HDL cholesterol levels
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
CA2294099A1 (en) Absorption of minerals
WO2001062290A3 (en) Methods and compositions for improving sleep
CA2271865A1 (en) Tablet composition
PT923315E (pt) Formula nutricional para pacientes com fenilcetonuria
WO2001026666A3 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
IL132992A0 (en) Method and compositions for administering taxanes orally to human patients
WO2001028526A3 (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
IL149360A0 (en) Method and compositions for administering taxanes orally to human patients
CA2395530A1 (en) Calcium formate for use as a phosphorus binder and a dietary supplement
CA2067243A1 (en) Compositions and methods for weight reduction
BRPI0411436A (pt) composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado
WO2001003683A3 (en) Cardioactive composition comprising l-carnitine and its derivatives and crataegus extracts
WO2001028570A3 (en) Zinc lactate lozenges and uses thereof
Cerrato Ginseng doesn't improve one's mood
Ahuja et al. An unusual presentation of scurvy following head injury
WO2001043757A3 (en) Composition comprising ingredients of panax ginseng and ginko biloba
CA2291974A1 (en) Composition comprising panax pseudo ginseng and eucommiae ulmoides
Donaldson et al. Comments on the paper by Garwin et al.(1992)
Hara A Histopathological and Histometrical Study on Initial Changes in the Denture Supporting Tissues by Pressure Exerted during Impression Pressure
Austin VITAMIN C REQUIREMENTS
ES2134865T3 (es) Uso de extracto de orujo de cerveza para la fabricacion de preparados de administracion oral.